Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 21. May 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9401  Previews Next
   
   Articles 1 - 20 / 188019  
   
Effectiveness of contemporary treatments for iatrogenic urethral strictures following endoscopic management of benign prostatic hyperplasia: a comprehensive review.
World J Urol
Lo Re M, Cadenar A, Pezzoli M, Fuligni E, Abbasi B, Bia, Chierigo F, Frankiewicz M, Karapanos L, Klemm J, Mantica G, Neuville P, Bucca B, Oszczud, Redmond E, Scherñuk J, Tinajero JD, Verla W, Minervini A, Vetterlein MW, Cocci A, Trauma and Reconstructive Urology Working Party of the European Association of Urology Young Academic Urologists.
PMID: 42165905 [PubMed - indexed for MEDLINE]


Androgen Receptor Expression in Urothelial Bladder Cancer-A Systematic Review and Meta-Analysis.
ANZ J Surg
Buckby A, Gholami M, Hong M, O'Callaghan M.
PMID: 42165524 [PubMed - as supplied by publisher]


Treatment and progression of patients in Sweden with metastatic castration-sensitive prostate cancer.
Acta Oncol
Styrke J, Jellvert Å, Hjälm Eriksson M, Sandin F, Axén E, Jabbar S, Juhl Norgaard K.
PMID: 42165189 [PubMed - indexed for MEDLINE]


Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery.
Eur Urol Open Sci
Tazawa S, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Narita T, Fujita N, Mikami J, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
PMID: 42164551 [PubMed]


The role of CD36 in renal and bladder cancer.
Discoveries (Craiova)
Pavalean MI, Madan VL, Pavalean MC, Ceafalan LC, Hinescu ME.
PMID: 42164471 [PubMed]


Meta-analysis of efficacy comparisons between standard- and low-dose Bacillus Calmette-Guerin vaccines in managing non-muscular invasive bladder cancer.
Oncol Lett
Liu X, Bao Y.
PMID: 42164465 [PubMed]


Bioinformatics analysis and experimental approach identify BRD-family gene DSP as a diagnostic and prognostic indicator in bladder cancer.
Transl Androl Urol
Liu Z, Tan T, Li S, Wang Y.
PMID: 42164400 [PubMed]


Advancing bladder cancer detection: commentary on a urinary DNA methylation diagnostic assay.
Transl Androl Urol
Duquesne I, Chakra MA, Myers AA, Boormans JL, Hayne D, Brown JA, O'Donnell MA.
PMID: 42164398 [PubMed]


Oncologic outcomes of transurethral resection versus laser excision for non-muscle invasive bladder cancer: a SEER retrospective cohort study.
Transl Androl Urol
Xia Y, Ma B, Huang T, Liu X.
PMID: 42164394 [PubMed]


Single-port robotic surgery for kidney and upper tract cancer: a narrative review.
Transl Androl Urol
Daher K, Soputro NA, Younis SK, Al-Bayati A, Bernardino R, Watfa M, Rai S, Wang L, Ghandour R, Kaouk J, Autorino R.
PMID: 42164392 [PubMed]


Machine learning-based integration identifies lactylation biomarkers for prognosis prediction and tumor microenvironment modulation in bladder cancer.
Transl Androl Urol
Zhou X, Weng L, Sun T, Jiang Q, Zeng F, Xu C, Chang C, Wang Y, Zhou J.
PMID: 42164391 [PubMed]


Association between systemic inflammatory response index and the prognosis of patients with localized and advanced renal cell carcinoma: a systematic review and meta-analysis.
Transl Androl Urol
Dai Q, Tan X, Huang P, Zhang J, Zhu H.
PMID: 42164378 [PubMed]


Prostate imaging reporting and data system version 2.1 as a predictor of clinically significant and aggressive prostate cancer: a radical prostatectomy-validated study.
Transl Androl Urol
Pisuchpen N, Eurboonyanun K, O'Shea A, Lahoud RM, Atre ID, Harisinghani M.
PMID: 42164375 [PubMed]


Distant metastasis prediction in renal carcinoma: a retrospective cohort study using interpretable machine learning.
Transl Androl Urol
Wang Y, Chen Y, Zhou Z, Ding Y, Yuan J.
PMID: 42164374 [PubMed]


Identification and diagnostic model construction of cuproptosis-related biomarkers in bone metastatic prostate cancer.
Transl Androl Urol
Li J, Yao S, Luo J, Li T, Zhang J.
PMID: 42164373 [PubMed]


Bibliometric study on hotspots and trends of immunotherapy for kidney cancer from 2014 to 2024.
Transl Androl Urol
Guo Q, Nie Z.
PMID: 42164368 [PubMed]


Pediatric non-rhabdomyosarcoma bladder tumors (NRBTs): a 20-year retrospective longitudinal cohort study at a tertiary referral center.
Transl Androl Urol
Huang Y, Fang Y, Song H, Zhang W, Sun N, Han W, Wang G, Liu C.
PMID: 42164361 [PubMed]


Prostate cancer screening and evidence: the role of overall survival.
Transl Androl Urol
Takahashi T.
PMID: 42164360 [PubMed]


Urinary PENK DNA methylation for bladder cancer diagnosis: methodological rigor, interpretive boundaries, and the evidence required for clinical translation.
Transl Androl Urol
Delrue C, Oyaert M, Speeckaert MM.
PMID: 42164358 [PubMed]


Robot-assisted simple prostatectomy vs. laser enucleation of the prostate for large-volume benign prostatic hyperplasia (BPH, ≥80 mL): a systematic review and meta-analysis.
Front Med (Lausanne)
Hao X, Wang S, Deng F, Li T, Chang F.
PMID: 42164167 [PubMed]


   
   Articles 1 - 20 / 188019    Page 1 of 9401  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1